Parallel Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Hold |
440
| – | – | ﹤0.01% | 2126 |
|
|
2025
Q1 | $19.8K | Sell |
440
-2
| -0.5% | -$90 | ﹤0.01% | 2135 |
|
|
2024
Q4 | $18.3K | Buy |
442
+2
| +0.5% | +$83 | ﹤0.01% | 2162 |
|
|
2024
Q3 | $17.2K | Buy |
440
+24
| +6% | +$936 | ﹤0.01% | 2160 |
|
|
2024
Q2 | $14.2K | Hold |
416
| – | – | ﹤0.01% | 2152 |
|
|
2024
Q1 | $10.5K | Hold |
416
| – | – | ﹤0.01% | 2293 |
|
|
2023
Q4 | $12.3K | Sell |
416
-20
| -5% | -$590 | ﹤0.01% | 2204 |
|
|
2023
Q3 | $13.8K | Hold |
436
| – | – | ﹤0.01% | 2043 |
|
|
2023
Q2 | $11.3K | Hold |
436
| – | – | ﹤0.01% | 2119 |
|
|
2023
Q1 | $10.5K | Buy |
436
+36
| +9% | +$865 | ﹤0.01% | 2108 |
|
|
2022
Q4 | $7.8K | Hold |
400
| – | – | ﹤0.01% | 2133 |
|
|
2022
Q3 | $8K | Hold |
400
| – | – | ﹤0.01% | 2070 |
|
|
2022
Q2 | $8K | Hold |
400
| – | – | ﹤0.01% | 2072 |
|
|
2022
Q1 | $9K | Hold |
400
| – | – | ﹤0.01% | 2059 |
|
|
2021
Q4 | $6K | Sell |
400
-553
| -58% | -$8.3K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $19K | Hold |
953
| – | – | ﹤0.01% | 1746 |
|
|
2021
Q2 | $16K | Buy |
953
+553
| +138% | +$9.28K | ﹤0.01% | 1777 |
|
|
2021
Q1 | $8K | Hold |
400
| – | – | ﹤0.01% | 1997 |
|
|
2020
Q4 | $7K | Hold |
400
| – | – | ﹤0.01% | 1914 |
|
|
2020
Q3 | $8K | Hold |
400
| – | – | ﹤0.01% | 1815 |
|
|
2020
Q2 | $7K | Hold |
400
| – | – | ﹤0.01% | 1845 |
|
|
2020
Q1 | $5K | Hold |
400
| – | – | ﹤0.01% | 1900 |
|
|
2019
Q4 | $10K | Buy |
+400
| New | +$10K | ﹤0.01% | 1723 |
|